ascendis transcon glp-1 program Science's 2023 Breakthrough: GLP-1R Agonists Ascendis Pharma sees massive growth

The allergist performed an oral challenge in the office where they tested my son and it turned out, he was NOT allergic to penicillin

* Correspondence: Azhagu Madhavan Sivalingam, [email protected]

Limitations in biomarker development and clinical translation: A major translational gap lies in the lack of stage-specific, ferroptosis-related biomarkers for predicting AKI-to-CKD progression

The focus will shift to how particular plant metabolites, fermentation byproducts, and cooking-generated compounds serve as exogenous triggers for these endogenous defense systems, thus elucidating the link between dietary intake and tangible physiological benefits

The authors have reviewed and edited the output and take full responsibility for the content of this publication

Watch the full episode here